top of page

POSTERS

Nonprescription syringe and overthe- counter naloxone availability in community pharmacies: A secret
Exploring opportunities to expand naloxone access and save lives on campus
Accessibility of office-based buprenorphine treatment for opioid use disorder in Texas
Evaluation of injection drug use and wound care practices of a mobile syringe services program
Policies and recommendation frequencies for medications for opiid use disorder in professional recov
Impact of a community immersion experience on student pharmacists' associated stigma of serious ment
Impact of interprofessional substance use disorder education on students' perceptions of addiction a
A wound care and immunization needs assessment for clients of a mobile syringe services program in A
Buprenorphine/naloxone film and naloxone nasal spray pharmacy deserts in Harris County, Texas and Ph
A qualitative report of fentanyl exposure among people who use drugs in Austin, Texas
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in ele
Analysis of Clinical Characteristics of Travis County Patients in a Central Texas Outpatient Substan
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Pen
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Ari
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Sou
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in Flo
Availability of buprenorphine/naloxone films in naloxone nasal spray in community pharmacies in Cali
Policies regarding use of medications for opioid use disorder in professional recovery programs: A s
Analysis of student pharmacists' self-reported intention to provide harm reduction resources after b
Description and Evaluation of a Novel Advanced Pharmacy Practice Experience (APPE) in Addiction Medi
Pedagogical Approaches to Optimizing Opioid-Related Outcomes: The Texas Opioid Training Initiative
Analysis of Patient-Reported Satisfaction with Long-Acting Injectables for Opioid and Alcohol Use Di
Isotonitazene as a contaminant of concern in the illegal opioid supply: a practical synthesis and co
bottom of page